BREAKWATER: Post-hoc subgroup efficacy analyses by chemotherapy ± bevacizumab regimens vs encorafenib plus cetuximab+mFOLFOX6 Meeting Abstract


Authors: Yoshino, T.; Kopetz, S.; Van Cutsem, E.; Wasan, H. S.; Eng, C.; Yaeger, R.; Kim, T. W.; Ciardiello, F.; Maughan, T.; Desai, J.; Fernandez, E. E.; Lonardi, S.; Shen, L.; Raphael, M.; Deming, D.; Usari, T.; King, A.; Rezai, N.; Zhang, X.; Tabernero, J.
Abstract Title: BREAKWATER: Post-hoc subgroup efficacy analyses by chemotherapy ± bevacizumab regimens vs encorafenib plus cetuximab+mFOLFOX6
Meeting Title: Ann. Oncol.
Journal Title: Annals of Oncology
Volume: 36
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2025-07-01
Start Page: S21
End Page: S22
Language: English
ACCESSION: WOS:001545246300037
DOI: 10.1016/j.annonc.2025.05.048
PROVIDER: wos
Notes: Meeting Abstract -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics